I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Change of NLRP3 Inflammasome Expression Level Symptoms and Functional Status in HFpEF Patients Treated With ARNI
In this study, investigators propose a scientific hypothesis that the expression of NLRP3 inflammasome is elevated in patients with HFpEF, and the level of TNF, IL-1 and NLRP3 inflammasome is lower in patients treated with sacubitril/valsartan.
diastolic dysfunction
ntprobnp
n-terminal pro-bnp
sacubitril
valsartan
- 0 views
- 19 Feb, 2024